InMed Pharmaceuticals (OTCMKTS:IMLFF – Get Rating) is one of 462 publicly-traded companies in the “Biotechnology” industry, but how does it compare to its competitors? We will compare InMed Pharmaceuticals to similar businesses based on the strength of its earnings, dividends, institutional ownership, risk, valuation, profitability and analyst recommendations. Profitability This table compares InMed Pharmaceuticals and […]